4//SEC Filing
Seymour Albert 4
Accession 0000899243-22-008060
CIK 0001661998other
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 4:05 PM ET
Size
7.9 KB
Accession
0000899243-22-008060
Insider Transaction Report
Form 4
Seymour Albert
Chief Scientific Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2022-02-24+128,000→ 128,000 totalExercise: $2.71Exp: 2032-02-24→ Common Stock (128,000 underlying) - Award
Restricted Stock Units
2022-02-24+21,000→ 21,000 total→ Common Stock (21,000 underlying)
Footnotes (3)
- [F1]The option vests in 48 substantially equal monthly installments on the first day of each calendar month following January 1, 2022.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date.
- [F3]The restricted stock units will vest and settle as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2022 so that such RSUs will become fully vested on January 1, 2025.
Documents
Issuer
Homology Medicines, Inc.
CIK 0001661998
Entity typeother
Related Parties
1- filerCIK 0001735324
Filing Metadata
- Form type
- 4
- Filed
- Feb 27, 7:00 PM ET
- Accepted
- Feb 28, 4:05 PM ET
- Size
- 7.9 KB